Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use

Abstract

The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.

1 - 29 . (canceled)  
   
   
       30 . A method for the treatment of at least one affective disorder or at least one bipolar disorder in a patient in need thereof, comprising administering to the patient a pharmacologically effective amount of eslicarbazepine acetate.  
   
   
       31 . The method according to  claim 30 , comprising administering to said patient an amount of eslicarbazepine acetate ranging between about 400 mg and about 2400 mg approximately every 24 hours.  
   
   
       32 . A method for the treatment of at least one manic symptom in a patient in need thereof, comprising administering to the patient a pharmacologically effective amount of eslicarbazepine acetate.  
   
   
       33 . A method for the maintenance treatment of at least one affective disorder or at least one bipolar disorder in a patient in need thereof, comprising administering to the patient a pharmacologically effective amount of eslicarbazepine acetate.  
   
   
       34 . The method according to  claim 33 , comprising administering to said patient an amount of eslicarbazepine acetate ranging between about 400 mg and about 2400 mg approximately every 24 hours.